Reading ZBH? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track ZBH free→Reading ZBH? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track ZBH free→QuarterlyIQ Insights · ZBH
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Regulation FD Disclosure. On May 12, 2026, Zimmer Biomet Holdings, Inc. (the “Company”) stated its intent to repurchase up to $1.0 billion of Company shares during fiscal year 2026 under the Company’s existing $1.5 billion share repurchase authorization, which had previously been approved by the Board of Directors of the Company in February 2026. This represents an increase from the Company’s previously-disclosed capital allocation assumptions for fiscal year 2026. The Company issued a press…
The filing appears to be related to a press release rather than a management change.
Chief Financial Officer and Executive Vice President – Finance, Operations and Supply Chain — Suketu Upadhyay: Mr. Upadhyay resigned to pursue a new professional opportunity.
Results of Operations and Financial Condition. On April 28, 2026, Zimmer Biomet Holdings, Inc. (the “Company”) issued a press release reporting its financial results for the quarter ended March 31, 2026. A copy of the press release is attached as Exhibit 99.1 and the information set forth therein is incorporated herein by reference and constitutes a part of this report. The information contained in this Item 2.02, including Exhibit 99.1, is being furnished and shall not be deemed to be “filed…
Results of Operations and Financial Condition. On February 10, 2026, Zimmer Biomet Holdings, Inc. (the “Company”) issued a press release reporting its financial results for the quarter and year ended December 31, 2025. A copy of the press release is attached as Exhibit 99.1 and the information set forth therein is incorporated herein by reference and constitutes a part of this report. The information contained in this Item 2.02, including Exhibit 99.1, is being furnished and shall not be deem…
named executive officer — Mark Bezjak: Mr. Bezjak resigned to pursue another business opportunity.
Other Events. On September 4, 2025, Zimmer Biomet Holdings, Inc. (the “ Company ”) issued two new series of senior unsecured debt securities denominated in Swiss francs, comprising CHF 210,000,000 aggregate principal amount of the Company’s 0.930% Bonds 2025 – 2030 (the “ Tranche A Bonds ”) and CHF 390,000,000 aggregate principal amount of the Company’s 1.560% Bonds 2025 – 2035 (the “ Tranche B Bonds ” and, together with the Tranche A Bonds, the “ Bonds ”). The Bonds were issued pursuant to a…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 29, 2021, Zimmer Biomet Holdings, Inc. (the “Company”) announced that Carrie Nichol, the Vice President, Controller and Chief Accounting Officer, and the principal accounting officer, of the Company, will be departing from the Company effective November 26, 2021. Ms. Nichol is pursuing another employment opportunity and her departure is…
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.